Trial Profile
Evaluation of Memantine for migraine prophylaxis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jul 2019
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 03 Jun 2014 New trial record